AtaiBeckley (ATAI) Change in Cash (2020 - 2026)
AtaiBeckley (ATAI) recorded quarterly Change in Cash of -$42.2 million in Q1 2026, down 237.09% quarter-over-quarter from $30.8 million in Q1 2025, and down 237.09% on a YoY basis from $30.8 million in Q1 2025.
AtaiBeckley (ATAI) Change in Cash (2020 - 2026) Analysis & Trends
AtaiBeckley has disclosed Change in Cash across 6 years of filings, most recently posting -$31.5 million for Q3 2025.
- Change in Cash for Q3 2025 came in at -$31.5 million, down 396.69% year-over-year; the trailing twelve-month figure through Sep 2025 was -$14.6 million (up 53.82% YoY), and the FY2024 annual result was -$17.5 million, up 87.96% from the prior year.
- Change in Cash was -$42.2 million for Q1 2026 at AtaiBeckley, down from $30.8 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $30.8 million in Q1 2025 to a low of -$42.2 million in Q1 2026.
- The 5-year median for Change in Cash is -$11.2 million (2024), against an average of -$3.5 million.
- Across the five-year window, Change in Cash sank 3445.37% in 2022 and jumped 685.59% in 2025, its largest moves.
- AtaiBeckley's Change in Cash stood at -$68.0 million in 2021, then jumped by 170.65% to $48.1 million in 2022, then sank by 165.44% to -$31.5 million in 2023, then soared by 44.5% to -$17.5 million in 2024, then sank by 80.65% to -$31.5 million in 2025.
- The last three Change in Cash figures came in at -$31.5 million (Q3 2025), $3.7 million (Q2 2025), and $30.8 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | -42.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.20 Mn |
| Sep 30, 2025 | -31.54 Mn |
| Jun 30, 2025 | 3.65 Mn |
| Mar 31, 2025 | 30.78 Mn |
| Mar 31, 2025 | 30.78 Mn |
| Dec 31, 2024 | -17.46 Mn |
| Sep 30, 2024 | 10.63 Mn |
| Jun 30, 2024 | 465,000.00 |
| Mar 31, 2024 | -11.17 Mn |
| Dec 31, 2023 | -31.46 Mn |
| Sep 30, 2023 | -64.60 Mn |
| Jun 30, 2023 | -44.80 Mn |
| Mar 31, 2023 | -4.73 Mn |
| Dec 31, 2022 | 48.07 Mn |
| Sep 30, 2022 | 58.41 Mn |
| Jun 30, 2022 | -39.84 Mn |
| Mar 31, 2022 | -238.29 Mn |
| Dec 31, 2021 | -68.04 Mn |
| Sep 30, 2021 | -23.31 Mn |
| Jun 30, 2021 | 349.25 Mn |